WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 4.06% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2026-06-30 was 4.06%, a 2.27% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2026-03-31 was 3.72%, a 7.46% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-06-30 was 3.97%, a 7.03% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-03-31 was 4.02%, a 2.66% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.77%, a 8.72% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 4.13%.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2021 was 0.84%, a 147.06% increase from fiscal 2020.
- WHITEHAWK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2020 was 0.34%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.06% 10-Q · filed 2026-08-06 | 3.72% 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 3.72% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 3.77% 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 3.94% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 3.97% 10-Q · filed 2026-08-06 | 3.97% 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 4.02% 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 4.13% 10-K · filed 2026-03-12 | |||
| 2024-09-30 | 4.13% 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 4.27% 10-Q · filed 2025-08-07 | 4.13% 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 4.13% 10-Q · filed 2025-05-08 | |||
| 2023-03-31 | 3.42% 10-Q · filed 2024-05-08 | |||
| 2022-03-31 | 1.46% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 0.84% 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 0.84% 10-Q · filed 2021-11-10 | 0.84% 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | 0.34% 10-K · filed 2022-03-17 | |||
| 2020-09-30 | 0.34% 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |